Biotech

All Articles

Zephyrm finds Hong Kong IPO to money period 3 cell treatment tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, filing (PDF) for an IPO to mone...

Frazier Lifestyle Sciences collects $630M for little, mid-cap biotechs

.Frazier Everyday life Sciences has sourced a further $630 thousand for its own fund paid attention ...

GigaGen achieves around $135M BARDA bucks to hammer botulism

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its...

GPCR agency Septerna declare IPO on strength of preclinical information

.Septerna will find out exactly how a biotech without "any kind of meaningful medical data" meals in...

Kurma finalizes to begin with $154M loot for greatest biotech fund as yet

.International VC company Kurma Allies has actually introduced its most current biotech fund, along ...

Prothena advertises one director while yet another keeps-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings ...

Editas capitalize Vertex Cas9 licensing legal rights for $57M

.Versus the scenery of a Cas9 license fight that rejects to die, Editas Medicine is moneying in a ch...

Ultragenyx fine-tunes genetics therapy application to dial up effectiveness

.A minority of clients taking Ultragenyx Pharmaceutical's Wilson condition gene therapy UX701 have a...

Biopharma cutback cost supports in Q3: Ferocious Biotech evaluation

.As summer months heat energy looks to cool down winds, really hopes that this year would certainly ...

J &amp J goes down stage 2 dengue prospect in most up-to-date switch coming from vaccines

.Johnson &amp Johnson's deprioritization of its transmittable ailment pipe has actually professed on...